EUA
TaqPath COVID-19 RNase P Combo Kit 2.0
FDA Emergency Use Authorization · Thermo Fisher Scientific Inc. · Mar 31, 2023
Key facts
| Product | TaqPath COVID-19 RNase P Combo Kit 2.0 |
|---|---|
| Company | Thermo Fisher Scientific Inc. |
| Product type | Real-time RT-PCR, Screening, Home Collection, Multiple Targets |
| Date | Mar 31, 2023 |
| FDA page | fda.gov |
At a glance
- 1–9 Authorization documents
- 1–9 EUAs for this company
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Emergency Use Authorizations
Emergency Use Authorizations allow the FDA to permit unapproved medical products, or unapproved uses of approved products, during a declared public health emergency.
Source: U.S. Food and Drug Administration (FDA), Emergency Use Authorizations · Source date: